| 000 | 01694 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516151736.0 | ||
| 264 | 0 | _c20140108 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.00558-13 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBolhuis, M S | |
| 245 | 0 | 0 |
_aClinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cAug 2013 |
||
| 300 |
_a3676-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Validation Study | ||
| 650 | 0 | 4 |
_aAcetamides _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aClarithromycin _xanalogs & derivatives |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aOxazolidinones _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSaliva _xchemistry |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _avan Altena, R | |
| 700 | 1 | _avan Hateren, K | |
| 700 | 1 | _ade Lange, W C M | |
| 700 | 1 | _aGreijdanus, B | |
| 700 | 1 | _aUges, D R A | |
| 700 | 1 | _aKosterink, J G W | |
| 700 | 1 | _avan der Werf, T S | |
| 700 | 1 | _aAlffenaar, J W C | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 57 _gno. 8 _gp. 3676-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.00558-13 _zAvailable from publisher's website |
| 999 |
_c22766384 _d22766384 |
||